Kodiak Sciences

Kodiak Sciences is a clinical-stage biopharmaceutical company based in Palo Alto, California. Founded in 2009, the company focuses on discovering, developing, and commercializing new therapeutics for chronic ophthalmic diseases, particularly those affecting the retina. Kodiak Sciences aims to prevent and treat leading causes of blindness by advancing innovative therapies that enhance patient outcomes. The company is dedicated to addressing significant challenges in eye health through its product development pipeline, which includes novel therapeutics for retinal diseases. Kodiak Sciences serves patients suffering from vision impairment and healthcare providers in ophthalmology, offering new treatment options that aim to improve the standard of care in eye health. With a strong commitment to ophthalmology, Kodiak Sciences is focused on making a positive impact on the lives of patients globally.